Sanofi
SNY
S$61.71
Share price
0.38%
Change (1 day)
-8.34%
Change (1 year)
Categories
Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthélabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.
Sanofi (SNY) - Total debt
Total debt on the balance sheet as of March 2025 : S$28.97 Billion
According to Sanofi's latest financial reports the company's total debt is S$28.97 Billion. A company’s total debt is the sum of all current and non-current debts.
Sanofi - Total debt on balance sheet (from 2002 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | S$25.32 B | -5.83% |
| 2023-12-31 | S$26.89 B | -11.83% |
| 2022-12-31 | S$30.50 B | -11.11% |
| 2021-12-31 | S$34.31 B | -5.91% |
| 2020-12-31 | S$36.47 B | -6.88% |
| 2019-12-31 | S$39.16 B | 1.71% |
| 2018-12-31 | S$38.50 B | 53.81% |
| 2017-12-31 | S$25.03 B | -11.48% |
| 2016-12-31 | S$28.28 B | 10.47% |
| 2015-12-31 | S$25.60 B | 7.55% |
| 2014-12-31 | S$23.80 B | -6.74% |
| 2013-12-31 | S$25.52 B | 8.61% |
| 2012-12-31 | S$23.50 B | -9.47% |
| 2011-12-31 | S$25.96 B | 83.47% |
| 2010-12-31 | S$14.15 B | -20.29% |
| 2009-12-31 | S$17.75 B | 47.86% |
| 2008-12-31 | S$12.00 B | -3.81% |
| 2007-12-31 | S$12.48 B | -11.16% |
| 2006-12-31 | S$14.05 B | -36.21% |
| 2005-12-31 | S$22.02 B | -37.91% |
| 2004-12-31 | S$35.47 B | 4411.19% |
| 2003-12-31 | S$0.78 B | 4.11% |
| 2002-12-31 | S$0.75 B | 14.36% |
| 2001-12-31 | S$0.66 B | -1.81% |
| 2000-12-31 | S$0.67 B | -12.91% |
| 1999-12-31 | S$0.77 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Merck MRK | S$44.34 B | 53.02% | 🇺🇸 USA |
 Pfizer PFE | S$77.99 B | 169.17% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | S$65.20 B | 125.02% | 🇺🇸 USA |
 Novartis NVS | S$39.79 B | 37.33% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | S$30.30 B | 4.59% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | S$21.55 B | -25.61% | 🇮🇱 Israel |
 Johnson & Johnson JNJ | S$66.49 B | 129.47% | 🇺🇸 USA |
 Eli Lilly LLY | S$49.01 B | 69.15% | 🇺🇸 USA |
 Novo Nordisk NVO | S$21.90 B | -24.39% | 🇩🇰 Denmark |
 Abbott Laboratories ABT | S$16.85 B | -41.85% | 🇺🇸 USA |